Resources & FAQs

Your resource center for MYCAPSSA.

If you’re considering the move to MYCAPSSA for acromegaly treatment, be sure to check out these helpful resources.

Icon of a brochure Icon of a brochure

MYCAPSSA Patient Brochure

Wondering if MYCAPSSA could be right for you? This brochure may help you and your doctor take the next step together.
Download
Download
Icon of a checklist Icon of a checklist

Patient Support Overview

Discover the comprehensive and personalized support you will get with Chiesi Total CareSM.
Learn More
Learn More
Black and white photo of 2 hands tapping the screen of a smartphone Black and white photo of 2 hands tapping the screen of a smartphone
Watch MYCAPSSA Patient Stories
Jim thumbnail
Jim's story of hope
Watch Jim as he talks about life with MYCAPSSA, and the support he's received along the way. Listen as he encourages others with acromegaly to advocate for themselves.
Jim thumbnail
Becky's move to MYCAPSSA
Listen as Becky talks about transitioning to treatment with MYCAPSSA, and how she's made it fit into her everyday life.
Jim thumbnail
Bonnie's story of perseverance
Watch as Bonnie talks about her experience with acromegaly symptoms, and why she decided to switch to treatment with MYCAPSSA.

Frequently Asked Questions About MYCAPSSA

MYCAPSSA is an oral prescription medicine approved for use in the long-term maintenance treatment of acromegaly in people who have responded to and tolerated treatment with octreotide or lanreotide.

If these treatments are effective and your body is tolerating it, you may be eligible to take MYCAPSSA instead of the injections.

If your current SSA treatment is effective and your body is tolerating it, you may be eligible to take oral MYCAPSSA capsules instead of your monthly injections.

The most common side effects of MYCAPSSA are headache, joint pain, nausea, weakness, diarrhea, and excessive sweating. Learn more about possible side effects in our Safety Profile.

MYCAPSSA is the oral version of octreotide, a medication you may already be familiar with.

Once swallowed with water, the coating on the capsule protects the medicine from being released too early or broken down before it gets to where it needs to be. The coating keeps the octreotide intact until it can make it to the right place in your body, your small intestine, to let the medication start to do its job.

Yes, MYCAPSSA was proven to effectively maintain normal IGF-I and growth hormone levels in the majority of patients. Learn more about consistent control and the proven Benefits of MYCAPSSA.

GH, growth hormone; IGF-I, insulin-like growth factor 1.

Once you start MYCAPSSA, your doctor may work with you to adjust your dose, depending on your IGF-I levels and your acromegaly signs and symptoms. Majority of patients in clinical trials received a 60 mg-dose of MYCAPSSA or higher.

Make sure to have an open dialogue about how you feel, and let your doctor know how MYCAPSSA is working for you. This will help ensure that you are receiving the right amount of medicine to properly manage your acromegaly. Do not stop taking MYCAPSSA before speaking with your doctor or pharmacist.

Take your dose of MYCAPSSA twice daily, morning and evening. Take MYCAPSSA on an empty stomach (1 hour before or 2 hours after a meal) with a glass of water.

If you forget to take your dose of MYCAPSSA, do not take the missed dose at a later time. Just take the next dose at the scheduled time. Call your doctor right away if you are having trouble regularly taking your doses. Not taking MYCAPSSA consistently may affect how you feel and how well the medicine can work for you.

MYCAPSSA will be delivered monthly to your home or designated location. The Chiesi Total CareSM team will work with you to deliver MYCAPSSA when and where it’s most convenient for you. You should receive a call from the pharmacy to confirm the shipment. Learn more about Chiesi Total CareSM.

Commercially insured patients can get MYCAPSSA for as little as $0 out of pocket, based on eligibility. The Chiesi Total CareSM team is here to guide you and your doctor's office through the process of getting started on MYCAPSSA therapy. For more information and for help understanding how MYCAPSSA works with your insurance plan, call 1-833-346-2277, Monday–Friday, 7:00 AM-7:00 PM CST.

Amryt Assist is now Chiesi Total CareSM. The dedicated Chiesi Total CareSM team will be there every step of the way to help make accessing, starting, and staying on MYCAPSSA treatment as easy as possible. They will help facilitate communication between you, your doctors, your specialty pharmacy, and your insurance company to make the transition to MYCAPSSA as seamless as possible. Learn more about Chiesi Total CareSM.

Yes! Your specialty pharmacy will help you stay on track with your refills of MYCAPSSA. Your pharmacy will reach out each month to coordinate a convenient delivery time for your refill. If any questions or issues arise, you can always contact the Chiesi Total CareSM team for further assistance.

Before first use, store unopened wallets of MYCAPSSA in a refrigerator. Be sure not to freeze your MYCAPSSA. After the first use for each wallet, you can store opened wallets at room temperature between 68°F to 77°F (20°C to 25°C) for up to one month. Be sure to keep your MYCAPSSA in a safe place and always out of the reach of children. 

MYCAPSSA is an oral form of octreotide, taken twice a day.

Somavert® (pegvisomant for injection) is a subcutaneous injection, self-administered once daily after a physician-supervised initial loading dose. Somatuline® Depot (lanreotide) is for deep subcutaneous injection only, initially administered every 4 weeks by a healthcare professional. Sandostatin® LAR Depot (octreotide acetate) and Signifor® LAR (pasireotide) are intramuscular injections, administered monthly by a healthcare professional.

Patients who respond to and tolerate octreotide or lanreotide may be eligible to take MYCAPSSA.

*Somavert® is a registered trademark of Pfizer Inc.
Somatuline Depot is a registered trademark of Ipsen Pharma S.A.S.
Sandostatin® is a registered trademark of Novartis Pharmaceuticals Corporation.
§Signifor® is a licensed trademark of Recordati Rare Diseases Inc.
||Please refer to the full Prescribing Information for each product for full Dosage and Administration information.

Want us to contact your healthcare team about MYCAPSSA for acromegaly treatment?

We're on it.

Share your doctor’s contact information, and the Chiesi Total CareSM team will reach out and talk to them about MYCAPSSA. We can help ensure that your healthcare provider has the information that he or she needs so that during your next appointment you can have an informed discussion of MYCAPSSA.
*Required Fields.
Please enter the following information in the form below:

Taking the first step, together.

We can help you and your doctor prepare for your MYCAPSSA chat.
Thanks for your interest in informing your healthcare team about MYCAPSSA. We’ll be in touch with them shortly.
RETURN TO HOMEPAGE
Black and white photo of 2 hands typing on a laptop

Important Safety Information

WHAT IS THE MOST IMPORTANT SAFETY INFORMATION I SHOULD KNOW?

MYCAPSSA can cause problems with the gallbladder. Tell your healthcare provider if you have any of these symptoms: sudden pain in your upper right stomach (abdomen) or right shoulder or between your shoulder blades; yellowing of your skin or the whites of your eyes; fever with chills; or nausea.

MYCAPSSA may affect your blood sugar, thyroid hormone, or vitamin B12 levels. Tell your healthcare provider if you have any problems or conditions related to these. Your healthcare provider may monitor these levels during your treatment with MYCAPSSA.

Tell your healthcare provider if you have an irregular heartbeat.

WHO SHOULD NOT USE MYCAPSSA?

MYCAPSSA can cause a serious allergic reaction including anaphylactic shock. Stop taking MYCAPSSA right away and get emergency help if you have any of these symptoms: swelling of your tongue, throat, lips, eyes or face; trouble swallowing or breathing; severe itching of the skin with rash or raised bumps; feeling faint; chest pain; or rapid heartbeat.

Do not use MYCAPSSA if you are allergic to octreotide or any other ingredients in MYCAPSSA. If you need to know the ingredients, ask your healthcare provider or pharmacist.

If you have certain other medical conditions, you should use MYCAPSSA with caution. Tell your healthcare provider about all your medical conditions, especially the following: pregnancy or breastfeeding; liver disease; kidney disease; or difficulty in emptying bladder completely.

Women taking an oral contraceptive should use an alternative non-hormonal method of contraception or a back-up method when taking MYCAPSSA. Tell your healthcare provider about all the medicines you take. MYCAPSSA may affect the way other medicines work, and other medicines may affect how MYCAPSSA works.

WHAT ARE THE POSSIBLE SIDE EFFECTS OF MYCAPSSA?

The most common side effects are headache, joint pain, nausea, weakness, diarrhea, and sweating a lot.

Please contact Chiesi Farmaceutici S.p.A. at 1-888-661-9260 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Keep MYCAPSSA and all medicines out of the reach of children.

HOW SHOULD I TAKE MYCAPSSA?

Do not take MYCAPSSA with food. MYCAPSSA should be taken with a glass of water on an empty stomach. Take MYCAPSSA at least 1 hour before a meal or at least 2 hours after a meal (for example, you could take your morning dose 1 hour before breakfast and your evening dose at bedtime).

Please see full Prescribing Information, including Medication Guide.

Indication

WHAT IS MYCAPSSA (octreotide) FOR?

MYCAPSSA is an oral prescription medicine used in the long-term maintenance treatment of acromegaly in people for whom treatment with octreotide or lanreotide has been effective and tolerated.

If these treatments are effective and your body is tolerating it, you may be eligible to take MYCAPSSA instead of the injections. Ask your doctor if this oral treatment is appropriate for you.

Important Safety Information

WHAT IS THE MOST IMPORTANT SAFETY INFORMATION I SHOULD KNOW?

MYCAPSSA can cause problems with the gallbladder. Tell your healthcare provider if you have any of these symptoms: sudden pain in your upper right stomach (abdomen) or right shoulder or between your shoulder blades; yellowing of your skin or the whites of your eyes; fever with chills; or nausea.

MYCAPSSA may affect your blood sugar, thyroid hormone, or vitamin B12 levels. Tell your healthcare provider if you have any problems or conditions related to these. Your healthcare provider may monitor these levels during your treatment with MYCAPSSA.

Tell your healthcare provider if you have an irregular heartbeat.

WHO SHOULD NOT USE MYCAPSSA?

MYCAPSSA can cause a serious allergic reaction including anaphylactic shock. Stop taking MYCAPSSA right away and get emergency help if you have any of these symptoms: swelling of your tongue, throat, lips, eyes or face; trouble swallowing or breathing; severe itching of the skin with rash or raised bumps; feeling faint; chest pain; or rapid heartbeat.

Do not use MYCAPSSA if you are allergic to octreotide or any other ingredients in MYCAPSSA. If you need to know the ingredients, ask your healthcare provider or pharmacist.

If you have certain other medical conditions, you should use MYCAPSSA with caution. Tell your healthcare provider about all your medical conditions, especially the following: pregnancy or breastfeeding; liver disease; kidney disease; or difficulty in emptying bladder completely.

Women taking an oral contraceptive should use an alternative non-hormonal method of contraception or a back-up method when taking MYCAPSSA. Tell your healthcare provider about all the medicines you take. MYCAPSSA may affect the way other medicines work, and other medicines may affect how MYCAPSSA works.

WHAT ARE THE POSSIBLE SIDE EFFECTS OF MYCAPSSA?

The most common side effects are headache, joint pain, nausea, weakness, diarrhea, and sweating a lot.

Please contact Chiesi Farmaceutici S.p.A. at 1-888-661-9260 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Keep MYCAPSSA and all medicines out of the reach of children.

HOW SHOULD I TAKE MYCAPSSA?

Do not take MYCAPSSA with food. MYCAPSSA should be taken with a glass of water on an empty stomach. Take MYCAPSSA at least 1 hour before a meal or at least 2 hours after a meal (for example, you could take your morning dose 1 hour before breakfast and your evening dose at bedtime).

Please see full Prescribing Information, including Medication Guide.

Indication

WHAT IS MYCAPSSA (octreotide) FOR?

MYCAPSSA is an oral prescription medicine used in the long-term maintenance treatment of acromegaly in people for whom treatment with octreotide or lanreotide has been effective and tolerated.

If these treatments are effective and your body is tolerating it, you may be eligible to take MYCAPSSA instead of the injections. Ask your doctor if this oral treatment is appropriate for you.